Guangdong Marubi Biotechnology Co Ltd
SSE:603983
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Guangdong Marubi Biotechnology Co Ltd
Cash from Operating Activities
Guangdong Marubi Biotechnology Co Ltd
Cash from Operating Activities Peer Comparison
1044
603605
300957
300146
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
|
Cash from Operating Activities
¥373.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Cash from Operating Activities
¥3.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Cash from Operating Activities
¥1.5B
|
CAGR 3-Years
42%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Cash from Operating Activities
¥610.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Cash from Operating Activities
¥2.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Cash from Operating Activities
¥1.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Guangdong Marubi Biotechnology Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
373.8m
CNY
Based on the financial report for Mar 31, 2024, Guangdong Marubi Biotechnology Co Ltd's Cash from Operating Activities amounts to 373.8m CNY.
What is Guangdong Marubi Biotechnology Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-5%
Over the last year, the Cash from Operating Activities growth was 438%. The average annual Cash from Operating Activities growth rates for Guangdong Marubi Biotechnology Co Ltd have been 5% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
